Guru Ownership Trend
Guru Analysis for BridgeBio Pharma, Inc. (BBIO)
BridgeBio Pharma, Inc. (BBIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.06 B.
Top institutional holders include Andreas Halvorsen and Chuck Royce.
Institutional sentiment is currently Bearish. This is evidenced by a $98.78 M net outflow during the quarter.
Recent activity highlights Ken Fisher who opened a new position. Conversely, Andreas Halvorsen reduced exposure by 9.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for BridgeBio Pharma, Inc. (BBIO)
Major holders include Andreas Halvorsen ($1.1 B), Chuck Royce ($17.82 M), Ken Fisher ($17.78 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 15.24 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $98.78 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited BBIO. The total reported sell value was $137.89 M.
Yes, 3 managers opened new positions in BBIO, and 1 increased their existing holdings. The total reported buy value was $39.11 M.